Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Vascular pharmacology of epoxyeicosatrienoic acids.

Pfister SL, Gauthier KM, Campbell WB.

Adv Pharmacol. 2010;60:27-59. doi: 10.1016/B978-0-12-385061-4.00002-7. Review.

2.

Epoxyeicosatrienoic acids and endothelium-dependent responses.

Campbell WB, Fleming I.

Pflugers Arch. 2010 May;459(6):881-95. doi: 10.1007/s00424-010-0804-6. Epub 2010 Mar 12. Review.

3.

Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.

Elmarakby AA.

Am J Physiol Regul Integr Comp Physiol. 2012 Feb 1;302(3):R321-30. doi: 10.1152/ajpregu.00606.2011. Epub 2011 Nov 23. Review.

4.

Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function.

Imig JD.

Prostaglandins Other Lipid Mediat. 2013 Jul-Aug;104-105:2-7. doi: 10.1016/j.prostaglandins.2013.01.002. Epub 2013 Jan 17. Review.

5.

EET signaling in cancer.

Panigrahy D, Greene ER, Pozzi A, Wang DW, Zeldin DC.

Cancer Metastasis Rev. 2011 Dec;30(3-4):525-40. doi: 10.1007/s10555-011-9315-y. Review.

6.

Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system.

Larsen BT, Campbell WB, Gutterman DD.

Trends Pharmacol Sci. 2007 Jan;28(1):32-8. Epub 2006 Dec 5. Review.

PMID:
17150260
7.

Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.

Imig JD.

Adv Pharmacol. 2016;77:105-41. doi: 10.1016/bs.apha.2016.04.003. Epub 2016 May 5. Review.

8.

Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.

Spector AA, Fang X, Snyder GD, Weintraub NL.

Prog Lipid Res. 2004 Jan;43(1):55-90. Review.

PMID:
14636671
9.

Epoxyeicosatrienoic acid pathway in human health and diseases.

Bellien J, Joannides R.

J Cardiovasc Pharmacol. 2013 Mar;61(3):188-96. doi: 10.1097/FJC.0b013e318273b007. Review.

PMID:
23011468
10.

Arachidonic acid cytochrome P450 epoxygenase pathway.

Spector AA.

J Lipid Res. 2009 Apr;50 Suppl:S52-6. doi: 10.1194/jlr.R800038-JLR200. Epub 2008 Oct 23. Review.

11.

Emerging role of epoxyeicosatrienoic acids in coronary vascular function.

Larsen BT, Gutterman DD, Hatoum OA.

Eur J Clin Invest. 2006 May;36(5):293-300. Review.

PMID:
16634832
12.

Action of epoxyeicosatrienoic acids on cellular function.

Spector AA, Norris AW.

Am J Physiol Cell Physiol. 2007 Mar;292(3):C996-1012. Epub 2006 Sep 20. Review.

13.

Roles of epoxyeicosatrienoic acids in vascular regulation and cardiac preconditioning.

Gauthier KM, Yang W, Gross GJ, Campbell WB.

J Cardiovasc Pharmacol. 2007 Dec;50(6):601-8. Review.

PMID:
18091575
14.

EETs/sEH in diabetes and obesity-induced cardiovascular diseases.

Huang H, Weng J, Wang MH.

Prostaglandins Other Lipid Mediat. 2016 Sep;125:80-9. doi: 10.1016/j.prostaglandins.2016.05.004. Epub 2016 May 13. Review.

PMID:
27184755
15.

Targeting epoxides for organ damage in hypertension.

Imig JD.

J Cardiovasc Pharmacol. 2010 Oct;56(4):329-35. doi: 10.1097/FJC.0b013e3181e96e0c. Review.

16.

Targeting soluble epoxide hydrolase for inflammation and pain - an overview of pharmacology and the inhibitors.

Pillarisetti S, Khanna I.

Inflamm Allergy Drug Targets. 2012 Apr;11(2):143-58. Review.

PMID:
22280237
17.

The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.

Fleming I.

Vascul Pharmacol. 2016 Nov;86:31-40. doi: 10.1016/j.vph.2016.03.001. Epub 2016 Mar 11. Review.

PMID:
26975734
18.

Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: a promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?

Bellien J, Joannides R, Richard V, Thuillez C.

Pharmacol Ther. 2011 Jul;131(1):1-17. doi: 10.1016/j.pharmthera.2011.03.015. Epub 2011 Apr 14. Review.

PMID:
21514320
19.

Cytochrome P450 eicosanoids and cerebral vascular function.

Imig JD, Simpkins AN, Renic M, Harder DR.

Expert Rev Mol Med. 2011 Mar 1;13:e7. doi: 10.1017/S1462399411001773. Review.

20.

Red blood cells (RBCs), epoxyeicosatrienoic acids (EETs) and adenosine triphosphate (ATP).

Jiang H, Anderson GD, McGiff JC.

Pharmacol Rep. 2010 May-Jun;62(3):468-74. Review.

Supplemental Content

Support Center